医院内侵袭性真菌感染的前瞻性研究
[Abstract]:Objective 1. To understand the characteristics of invasive fungal infection and drug resistance in the target population in our hospital, and to explore and analyze the risk factors of invasive fungal infection in hospital, so as to provide the characteristic for the study of invasive fungal infection in our hospital. Systematic and detailed research data provide objective reference for clinical prevention and treatment strategy. Methods A prospective controlled study was conducted with the target population admitted to the General Hospital of Ningxia Medical University from January 2011 to June 2012. The patients were followed up according to a unified questionnaire from the date of admission. The survey included age, length of stay, underlying diseases, invasive practices, use of antimicrobial agents and antifungal agents; Blood glucose, plasma albumin and other biochemical indicators, invasive fungal infection at the same time recorded the types of pathogens and drug sensitivity test results; The primary basic diseases, specimen sources, microflora distribution, bacterial species changes, drug susceptibility results, distribution, treatment and outcome of the patients with nosocomial invasive fungal infection were investigated and the related risk factors were analyzed. Results A total of 1226 patients were enrolled in this study, including 121 patients with invasive fungal infection, the incidence of invasive fungal infection was 9.87. Respiratory tract infection was the most common site of fungal infection, followed by urinary tract infection. 133 strains of fungi were isolated from blood, urine, sputum, pleural effusion, ascites and cerebrospinal fluid. Among them, 116 strains of candida, 14 strains of mold, 3 strains of Cryptococcus neoformans, and 75 strains of Candida albicans were the most common. The results of fungal susceptibility test showed that the sensitivity of antifungal drugs to fungi was significantly different. Conclusion 1.Respiratory tract is the most common site of invasive fungal infection, followed by urinary tract, blood infection has risen to the third place; (2) the invasive fungal infection tends to develop from single tissue / organ to multiple tissue / organ, and the invasive fungal infection becomes more and more complicated. 3, Candida albicans has a downward trend, but it is still the main pathogenic bacteria. Candida tropicalis in non-Candida albicans has become the second leading pathogen of invasive fungal infection, and Aspergillus albicans has been increasing year by year, becoming the third pathogenic bacteria. Candida albicans were resistant to 5-fluorocytosine, fluconazole and itraconazole to some extent, while non-Candida albicans were sensitive to these three drugs in a dose-dependent manner. 5, age 60 years, hospital stay longer than 30 days, severe underlying diseases, hyperglycemia, hypoproteinemia, long-term extensive use of broad-spectrum antibiotics, long-term use of hormones / immunosuppressants, Long-term invasive operation is a high risk factor for invasive fungal infection in our hospital.
【学位授予单位】:宁夏医科大学
【学位级别】:硕士
【学位授予年份】:2013
【分类号】:R519
【相似文献】
相关期刊论文 前10条
1 邵宗鸿;;血液科抗真菌治疗——国外指南解读[J];中国实用内科杂志;2008年07期
2 陈钰;张懋仁;;伊曲康唑注射液对血液系统疾病合并侵袭性真菌感染的治疗[J];中国实用内科杂志;2010年02期
3 朱利平;翁心华;;伊曲康唑在侵袭性真菌感染中的预防作用[J];中国新药与临床杂志;2006年11期
4 陈纯波;曾红科;胡北;叶珩;李辉;方明;霍家聪;何楷然;;伏立康唑治疗重症患者侵袭性真菌感染的疗效[J];广东医学;2008年07期
5 谭筱江;孟凡义;刘理想;徐丹;魏永强;徐兵;刘晓力;冯茹;孙竞;刘启发;;伊曲康唑治疗恶性血液病合并侵袭性真菌感染127例临床分析[J];中国实用内科杂志;2008年09期
6 张俊;阎凯;周德军;;两性霉素B治疗恶性血液病合并侵袭性真菌感染28例[J];齐齐哈尔医学院学报;2009年16期
7 王海燕;崔杰;黄祥;王玉兰;;卡泊芬净治疗老年患者侵袭性真菌感染临床分析[J];中国药物应用与监测;2009年05期
8 卢洪洲;沈银忠;;艾滋病患者侵袭性真菌感染的诊断[J];诊断学理论与实践;2010年06期
9 夏芝辉;贾宝辉;潘毅;陈军喜;韩飚;闫智杰;;伊曲康唑早期经验性治疗ICU侵袭性真菌感染临床研究[J];中国社区医师(医学专业);2011年20期
10 谷敏;;伏立康唑治疗血液系统恶性肿瘤并发侵袭性真菌感染的疗效分析[J];中外医学研究;2011年24期
相关会议论文 前10条
1 孙于谦;许兰平;刘代红;张晓辉;陈育红;王昱;陈欢;王峰蓉;王景枝;张圆圆;纪宇;刘开彦;黄晓军;;异基因造血干细胞移植后侵袭性真菌感染预后因素分析[A];第13届全国实验血液学会议论文摘要[C];2011年
2 赖永榕;王双月;李桥川;马R
本文编号:2370379
本文链接:https://www.wllwen.com/yixuelunwen/chuanranbingxuelunwen/2370379.html